GRP’s presentation provides insights on requirements and processes for requesting a De Novo classification request to the FDA.
GRP’s presentation provides an overview on the Establishment Registration with the FDA including who is required and not required to register.
GRP’s presentation outlines important information FDA OTC Monograph Reform.
GRP’s presentation outlines important information IND requirements with the US FDA.
GRP’s presentation provides an overview of the registration process for Drug Master File type II used for API registration with the US FDA.
We are a global consulting and market access firm headquatered in boston, massachusetts that provides regulatory affairs, quality, clinical andsafety services to pharma, biotech, lifestyle consumer companies worldwide for their product registration and compliance with the US FDA.